BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Clinical trial NCT02788513 · COMPLETED
Trial details
- NCT number
- NCT02788513
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-11
- Primary completion
- 2019-09-12
- Enrollment
- 611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.